Cue Biopharma, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
CUE on Nasdaq
Industry
Pharmaceutical Preparations
Location
40 Guest Street, Boston, MA

Insiders trading volume in the past year

Cue Biopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Aaron G.L. Fletcher Director $3.07M Jan 3, 2023
Michael J. Fox Director $3.04M Jun 5, 2024
Cameron Gray Director $1.9M Jun 14, 2022
Anish Suri President And Cso $374K Jun 5, 2024
Daniel Passeri CHIEF EXECUTIVE OFFICER, Director $170K +$30.9K +22.3% Mar 21, 2025
Colin Sandercock Svp, General Counsel Mar 21, 2025
Frank Morich Director Jan 2, 2025
Frederick Driscoll Director Jan 2, 2025
Tamar Howson Director Jan 3, 2023
Patricia Nasshorn Chief Business Officer Feb 16, 2023
Kenneth Pienta Chief Medical Officer Mar 25, 2022
Peter A. Kiener Director Jan 2, 2025
Pamela Garzone Director Jan 2, 2025
Matteo Levisetti Chief Medical Officer Mar 21, 2025
Patrick Verheyen Director Jan 2, 2025
Lucinda Warren Chief Business Officer Mar 21, 2025
Pasha Sarraf Director Mar 10, 2025
Daniel Baker Chief Development Officer Mar 21, 2025
Kerri-Ann Millar Chief Financial Officer Mar 21, 2025

Recent Insider Transactions by Companies or Individuals for Cue Biopharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.